Guard Therapeutics International AB (OSTO:GUARD) Total Equity: kr36.54 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:GUARD Guard Therapeutics International AB OSTO:GUARD
25 GF Score
Price kr1.58
! 1 Warning Sign
View Full Analysis

What is Guard Therapeutics International AB Total Equity?

Guard Therapeutics International AB OSTO:GUARD +1.15% 25 Total Equity is kr36.54 Mil as of Mar. 2026. GuruFocus rates OSTO:GUARD with a GF Score™ of 25/100. The stock has 1 warning sign investors should review.

Guard Therapeutics International AB's total equity for the quarter that ended in Mar. 2026 was kr36.54 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Guard Therapeutics International AB Total Equity Historical Data

* Premium members only.

The historical data trend for Guard Therapeutics International AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guard Therapeutics International AB Total Equity Chart

Guard Therapeutics International AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 175.78 177.36 66.73 37.97 40.63

Guard Therapeutics International AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.27 80.40 55.64 40.63 36.54
OSTO:GUARD
25GF Score
Guard Therapeutics International AB OSTO:GUARD
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guard Therapeutics International AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Guard Therapeutics International AB's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=54.143-13.512
=40.63

Guard Therapeutics International AB's Total Equity for the quarter that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=45-8.457
=36.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of kr36.54 Mil mean?
Guard Therapeutics International AB (OSTO:GUARD) has a Total Equity of kr36.54 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Guard Therapeutics International AB and its competitors.
Is Guard Therapeutics International AB's Total Equity too high?
Guard Therapeutics International AB's current Total Equity is kr36.54 Mil. Overall, Guard Therapeutics International AB has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Guard Therapeutics International AB's Total Equity compare to VRTX and REGN?
Guard Therapeutics International AB's Total Equity of kr36.54 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Guard Therapeutics International AB and its competitors. Guard Therapeutics International AB's current Total Equity is kr36.54 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guard Therapeutics International AB stock overvalued right now?
Guard Therapeutics International AB (OSTO:GUARD) has a current Total Equity of kr36.54 Mil. The current Total Equity is kr36.54 Mil. Guard Therapeutics International AB's overall GF Score™ is 25/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Guard Therapeutics International AB (OSTO:GUARD), the current Total Equity is kr36.54 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Guard Therapeutics International AB Business Description

Address Scheelevagen 22, Lund, SWE, 223 63
Guard Therapeutics International AB is engaged in developing and commercializing the lead drug candidate ROSgard, and thereby contribute to the better and less harmful treatment of acute kidney injuries.
25GF Score

Get the complete analysis for OSTO:GUARD

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr1.58
Price